Actinium Pharmaceuticals, Inc.

Financial Services · Biotechnology
Lately:2 news stories in 90 daysFollow changes →

Facts

as of Nov 17, 2026

Home About About Overview Management Team Board of Directors Partners About Actinium is a pioneer in the development of differentiated targeted radiotherapies intended to meaningfully improve patient outcomes.

Headquarters
New York, United States
Official records
Wikidata Q30270765
Website
actiniumpharma.com
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
SiteTypeOpen rolesHires most forEngineering
New York United StatesHeadquarters0
Source: office addresses in postings and company registers

Financials

2 public grants on record, $2.1M in total.

$2.1MPublic grants2 public grants
Money by yearUSD, rounds and grants
2023$1.7M1 record
2020$378k1 record
Largest rounds and grants
2023
$1.7M
2020
$378k
Sources: funding announcements, grant and company registers

Milestones

Aug 1, 2023
Won a grant $1.7M · CORDIS
Sep 9, 2020
Won a grant $378k · CORDIS
Each milestone is dated by its source: registers, filings, the press

Newsroom

Oct 12026
News · morningstar.com
Sep 42026
News · markets.ft.com
The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting rights, and directors and dealings.
Jun 12026
Press release · Nasdaq
--Actinium Pharmaceuticals, Inc., a pioneer in the development of targeted radiotherapies, on May 31, 2026 presented new radiochemistry data at the Society of Nuclear Medicine an…
May 302026
Press release · PRNewswire
/PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today...
May 62026
Press release · Nasdaq
--Actinium Pharmaceuticals, Inc., a pioneer in the development of targeted radiotherapies, today announced the upcoming presentation of three abstracts at the Society of Nuclear…
Sep 2, 20252025
News · YahooFinance
Here is how Actinium Pharmaceuticals (ATNM) and Avadel (AVDL) have performed compared to their sector so far this year.
Sources: the outlets named on each headline, each story once